PARANEOPLASTIC SYNDROMES AND COMPLICATIONS AFTER CHEMOTHERAPY IN SMALL ANIMALS

Authors

  • Zh. Koreneva Одеський державний аграрний університет
  • O. Ushakov Одеський державний аграрний університет
  • M. Khimych Одеський державний аграрний університет
  • O.V Naidich Одеський державний аграрний університет

DOI:

https://doi.org/10.37000/abbsl.2020.96.02

Keywords:

tumor, paraneoplastic syndromes, chemotherapy, complications, veterinary medicine

Abstract

Paraneoplastic syndromes are clinical symptoms, the development of which is caused by nonspecific reactions from the organs and systems of the sick body and the development of the tumor in the body. There are common features in the pathogenesis of the development of the syndrome: appearance only in the presence of a certain malignant tumor, nonspecific clinical manifestation; lack of communication with certain local changes in the affected organs and tissues; disappearance after removal of the tumor and the appearance again for relapse. Depending on the symptoms in clinical veterinary practice, paraneoplastic syndromes can be distinguished: endocrine, musculoskeletal, cardiovascular, dermatological, hematological, gastroenterological, nephrological, neurological, atypical and mixed.Recently, the diagnosis of tumors in animals has expanded significantly and improved, which makes it possible for veterinarians to diagnose tumors in the early stages and help animals. When prescribing chemotherapy drugs, healthy cells suffer in the first place, they are the ones that are damaged first, when using all antitumor drugs. The main disadvantage of chemotherapeutic drugs is the lack of strictly selective action of the drug, which would be aimed at neutralizing only tumor cells. Therefore, all drugs have a number of side effects and is an additional burden for the sick body

References

Давыдов М.И., Летягин В.П. Рак молочной железы. Атлас М.: АБВпресс, 2006. 136 с.

Игнатенко Н.А. Диагностика, лечение и прогноз некоторых круглоклеточных новообразований кожи у собак. VetPharma. №3. 2016.

Игнатенко Н.А. Паранеопластические дерматологические синдромы–как распознать? VetPharma. 2017. Р. 76-81

Лисихин А.А., Марьин Е.М., Пономаренко А.В. Диагностика злокачественных опухолей на основе показателей крови. Международный студенческий научный вестник. 2016. № 4-3.

Митрохина Н.В. Клинико-морфологическая характеристика опухолей молочных залоз у мелких домашних животных VetPharma. №5. 2016. С.50-53.

Пухлини тварин: етіологія, патогенез, дiагностика, комплексна терапія/ А. А. Гамота, В. I. Завiрюха, Я. Г. Крупник, А. Р. Мисак. Львiв: Галицька видавнича спiлка, 2007. 168 с.

Пухлини дрiбних свiйських тварин: клініка, дiагностика, лiкування / За ред. В. Ф. Чехуна, А. Й. Мазуркевича. Київ: Д1А, 2001. 164 с.

Сидорова К.А., Татарникова Н.А. Лимфопролиферативные заболевания мелких домашних животных Ветеринарная патология. № 3. 2018. С. 5-10

Хурані І.Ф., Ковальчук А.П. Паранеопластичний синдром як ранній прояв злоякісної пухлини. Шпитальна хірургія. 2009. № 1. С. 80-83.

Якунина М.Н., Голубева В.А., Д.В. Гаранин Рак молочной железы у собак и кошек. М.: Зоомедлит: Колос-с, 2010. 80 с.

Agarwala S.S. Paraneoplastic syndromes. Med Clin North Am. 1996. №80(1). Р.173-184.

Alabduljalil T, Behbehani R. Paraneoplastic syndromes in neuroophthalmology. Curr Opin Ophthalmol. 2007. №18(6). Р.463-469.

Back A, Schleis S, Smrkovski O, Smith A, Lee J, Phillips J. Mechlorethamine, vincristine, melphalan, and prednisone (MOMP) for the treatment of relapsed lymphoma in dogs. Vet Comparative Oncol 5 AUG. 2013.

Chung L.W., Baseman A, Assikis V, Zhau H.E. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.. J. Urol. 2005 Jan; 173(1). Р.10-20.

Merrick C, Smith AN, Schleis SE, Mallett C, Graff E, Weiss R. Hypercalcemia of malignancy associated with renal cell carcinoma in a dog. J Am Animal Hosp Assoc 2013. 49. 385-388.

Hall T.C. Paraneoplastic syndromes: mechanisms. Semin Oncol. 1997.№ 24(3). Р.269-276.

Honnorat, J., Antoine, J. Paraneoplastic neurological syndromes. Orphanet J. Rare Dis 2, 22. 2007

Odell W.D. Paraendocrine syndromes of cancer. Adv Intern Med. 1989. №34 Р.325-351.

Pelosof L.C., Gerber D.E. Paraneoplastic syndromes: an approach to diagnosis and treatment. Mayo Clin Proc. 2010 85(9). Р.838-854.

Pelosof L.C., Gerber D.E.Раraneoplastic Syndromes. The American Cancer Society's Oncology in Practice: Clinical Management. 2018

Smits B., Reid M.M. Feline paraneoplastic syndrome associated with thymoma. New Zealand Veterinary Journal . 2003. №51. Р. 244–247.

Published

2020-07-21

How to Cite

Koreneva, Z., Ushakov, O., Khimych, M., & Naidich, O. (2020). PARANEOPLASTIC SYNDROMES AND COMPLICATIONS AFTER CHEMOTHERAPY IN SMALL ANIMALS. Agrarian Bulletin of the Black Sea Littoral, (96). https://doi.org/10.37000/abbsl.2020.96.02